05 October 2019 : Clinical Research
Interleukin-10 and Interleukin-1β Cytokines Expression in Leukocytes of Patients with Chronic Peri-Mucositis
Darius Gleiznys1ABCDEFG*, Alvydas Gleiznys1AD, Lina Abraškevičiūtė1CF, Astra Vitkauskienė2C, Viktoras Šaferis3C, Jurgina Sakalauskienė1ABEDOI: 10.12659/MSM.915464
Med Sci Monit 2019; 25:7471-7479
Abstract
BACKGROUND: The purpose of the present research is to analyze the effect of polyphenols and flavonoids substrat (PFS) from plants Calendula officinalis, Salvia fruticosa, Achillea millefolium, and propolis as immunomodulatory in the production of interleukin (IL)-1β and IL-10 in peripheral blood leukocytes medium (PBLM) in patients who were diagnosed with mucositis of peri-implant tissue compared to patients with healthy implant tissue. It was hypothesized that IL-1β and IL-10 contribute to the inflammation processes noticed in the diseases of peri-implant tissues.
MATERIAL AND METHODS: Sixty non-smoking patients were included in this study: patients with healthy implants (HP group) and patients with peri-implant mucositis (MP group). Peri-mucositis was diagnosed by radiologic and clinical examination. The PBLM from MP were treated with PFS at various concentrations. The levels of IL-10 and IL-1β excreted by the PBLM stimulated and unstimulated with viable Porphyromonas gingivalis test-tube were committed by the enzyme amplified immunoassay sensitivity method.
RESULTS: Unstimulated and stimulated PBLM and treatment with 5.0 mg/mL or 10.0 mg/mL of PFS in the MP group produced significantly higher levels IL-10 (P<0.001) that analogous mediums of the HP group. The levels of IL-1β decreased more considerably in the stimulated PBLM of the MP group than in those of HP group (P<0.001) after the treatment with PFS at only 10.0 mg/mL concentration.
CONCLUSIONS: Theses results suggest that the solution of PFS might offer a new potential for the development of a new therapeutic path to prevent and treat peri-implant mucositis.
Keywords: Interleukin-10, Leukocytes, mucositis
Editorial
01 January 2025 : Editorial
Editorial: The Human Cell Atlas. What Is It and Where Could It Take Us?DOI: 10.12659/MSM.947707
Med Sci Monit 2025; 31:e947707
In Press
Clinical Research
Quantifying Gait Asymmetry in Stroke Patients: A Statistical Parametric Mapping (SPM) ApproachMed Sci Monit In Press; DOI: 10.12659/MSM.946754
Laboratory Research
Effect of Irrigation Solution Temperature on Bioceramic Sealer Bond StrengthMed Sci Monit In Press; DOI: 10.12659/MSM.946772
Clinical Research
Impact of Smovey Vibration Versus Dumbbell Resistance on Muscle Activation in WomenMed Sci Monit In Press; DOI: 10.12659/MSM.946567
Clinical Research
Five-Year Impact of Weight Loss on Knee Pain and Quality of Life in Obese PatientsMed Sci Monit In Press; DOI: 10.12659/MSM.946550
Most Viewed Current Articles
17 Jan 2024 : Review article 6,962,831
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 699,975
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 23,256
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 17,976
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912